Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
l�ll
Validation of analytic methods for biomarkers used in drug development Chau CH; Rixe O; McLeod H; Figg WDClin Cancer Res 2008[Oct]; 14 (19): 5967-76The role of biomarkers in drug discovery and development has gained precedence over the years. As biomarkers become integrated into drug development and clinical trials, quality assurance and, in particular, assay validation become essential with the need to establish standardized guidelines for analytic methods used in biomarker measurements. New biomarkers can revolutionize both the development and use of therapeutics but are contingent on the establishment of a concrete validation process that addresses technology integration and method validation as well as regulatory pathways for efficient biomarker development. This perspective focuses on the general principles of the biomarker validation process with an emphasis on assay validation and the collaborative efforts undertaken by various sectors to promote the standardization of this procedure for efficient biomarker development.|*Drug Design[MESH]|Animals[MESH]|Antineoplastic Agents/*pharmacology[MESH]|Biomarkers[MESH]|Biomarkers, Pharmacological/*analysis[MESH]|Biomarkers, Tumor/*metabolism[MESH]|Chemistry, Pharmaceutical/*methods[MESH]|Drug Evaluation, Preclinical/*methods[MESH]|Genome, Human[MESH]|Genomics[MESH]|Humans[MESH]|Medical Oncology/*methods[MESH]|Mice[MESH]|Neoplasms/*drug therapy[MESH]|Treatment Outcome[MESH] |